Loading clinical trials...

Predictive Outcomes for Selective Thumb Carpometacarpal Joint Denervation | Clinical Trials | Clareo Health

Not Yet RecruitingNANCT06467669

Predictive Outcomes for Selective Thumb Carpometacarpal Joint Denervation

Background: The thumb (or first) carpometacarpal (CMC) joint is commonly affected by osteoarthritis. Literature has reported a prevalence of 15% in women and 7% in men. First CMC joint osteoarthritis ...

Lead sponsor: University of Calgary•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Alexander Platt, MD

CONTACT

4036045130 alexander.platt@ucalgary.ca

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment60

Start dateJul 2024

Last updatedJun 21, 2024

Condition

CMC Arthritis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2024Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions